IL15 and in situ carcinoma: To determine whether the increased IRI-induced inflammation in allografts subjected to prolonged CIS would alter the graft DC populations producing IL-15, we harvested high-ischemic IL-15 reporter allografts from BALB/c recipients and observed the dominant IL-15 expression in the graft DC2 versus DC1 cells similar to that observed in low-ischemic allografts from recipients treated with p40HD (Figure 4D and Figure 5C).